While the industry has been focusing on the clinical safety advantages of TPE infusion sets—such as being DEHP-free, non-drug-absorbent, and biocompatible—a widely overlooked core perspective is reshaping the value of this sector. The true competitiveness of TPE infusion sets lies not only in clinical safety but also in their green value across the entire lifecycle: from raw materials, production, and usage to disposal. They represent the integration of safety, environmental protection, and cost efficiency in medical consumables, and serve as a critical carrier for ESG compliance and carbon neutrality goals in medical institutions and enterprises.
I. The Underestimated “Green Genes”: Essential Differences Between TPE and PVC Across the Lifecycle
The “environmental original sin” of traditional PVC infusion sets extends far beyond clinical safety. During production, PVC requires 30%–40% DEHP plasticizer, and residual vinyl chloride monomer is carcinogenic. Incineration releases dioxins and hydrogen chloride, while landfilling causes long-term contamination of soil and groundwater. The disposal cost per ton of PVC medical waste is 800–1200 yuan higher than that of ordinary plastics, and PVC is subject to strict supervision under EU REACH regulations and domestic environmental policies.
In contrast, TPE (Thermoplastic Elastomer) inherently possesses green properties:
- Raw material stage: Made from medical-grade elastomers such as SEBS, TPE is free of plasticizers, halogens, and heavy metals. Its production process emits no VOCs, and energy consumption per unit product is 60% lower than that of PVC.
- Production stage: TPE is compatible with existing infusion set production lines without large-scale equipment retrofitting. Its injection/extrusion molding cycle is shortened by 15%, with a 40% reduction in defect rate. The overall production cost is only 8%–12% higher than PVC, and the gap narrows further with green procurement subsidies.
- Disposal stage: TPE is 100% recyclable, with an organic matter recovery rate of 92% after pyrolysis, and generates no persistent organic pollutants. Its carbon footprint is 35%–42% lower than PVC, fully complying with the requirement in the Guidelines for Green Manufacturing of Medical Devices to reduce hazardous substance usage by 30% by 2025.
This means TPE infusion sets are not merely a “material replacement”—they cut off the environmental hazard chain of medical consumables at the source, forming a full-chain green closed loop of safe production, safe usage, and safe disposal.
II. The “Hidden Value” in Clinical Scenarios: Beyond Safety, Toward Efficiency, Cost Reduction and Better Experience
The industry often limits the advantages of TPE to being “DEHP-free and non-drug-absorbent”. However, in real clinical practice, its material properties solve many neglected pain points:
- Precise flow control for efficient nursing: TPE combines rubber elasticity and plastic rigidity, with moderately flexible tubing. The flow regulator operates smoothly without slipping or jamming, enabling stable and accurate drip control—especially suitable for pediatrics, geriatrics, ICUs and other scenarios demanding high infusion precision, reducing repeated adjustments by nurses.
- Leak-proof sealing to lower HAI risks: TPE connectors and pistons feature excellent resilience, automatically sealing after puncturing bottle stoppers, with smooth insertion/removal and no fluid seepage or leakage. Stable performance and no deformation after sterilization effectively reduce the risk of drug contamination and cross-infection.
- Optimized touch for improved patient comfort: TPE tubing is soft and skin-friendly, avoiding the stiffness of PVC, minimizing friction and pressure on the skin during long-term infusion. It is particularly suitable for sensitive groups such as newborns and pregnant women, enhancing the overall infusion experience.
These “hidden values” ultimately translate into lower overall costs for medical institutions: reduced drug waste, lower costs for healthcare-associated infection management, and improved nursing efficiency. In the long run, the full-lifecycle usage cost of TPE infusion sets is actually lower than that of traditional PVC.
III. Dual Drivers of Policy and Market: The “Green Compliance Dividend” of TPE Infusion Sets
Since 2023, domestic environmental supervision of medical consumables has continuously tightened. The revised draft of the Medical Device Classification Catalogue requires the gradual phase-out of PVC in high-risk infusion devices. Environmental scores account for up to 15% in procurement by tertiary hospitals. As carbon quota trading pilots expand to the medical device industry, enterprises continuing to use PVC will face an annual increase of over 10 million yuan in compliance costs, with net profit margins compressed by 2–3 percentage points.
Meanwhile, global demand for green medical consumables is surging. New EU MDR regulations explicitly require recyclable medical materials, and the SUP ban has opened a €2 billion market for non-PVC infusion sets. Leading domestic enterprises such as Wego Group have obtained “Green Design Product” certifications for their TPE infusion sets, making them the preferred choice for tertiary hospitals and high-end private hospitals.
For enterprises, deploying TPE infusion sets is not only a “mandatory compliance choice” but also a first-mover advantage in seizing the green medical sector. It avoids environmental penalties, enhances product premium through “green labeling”, and meets the ESG assessments and carbon neutrality targets of medical institutions, forming a positive cycle of safety, environmental protection and economic benefits.
IV. Future Trends: Directions for the “Green Upgrade” of TPE Infusion Sets
The green value of TPE infusion sets still has great potential for exploration, with the industry iterating in three directions:
- Customized green formulations: Develop low-hardness, high-transparency, irradiation-sterilization-resistant TPE formulations for light-proof infusion, precision filtration, pediatric use and other scenarios, further improving material adaptability and environmental performance.
- Closed-loop recycling systems: Drawing on the experience of enterprises such as Fresenius, establish a closed loop of “hospital collection → professional pyrolysis → raw material regeneration → finished product production” to realize the circular utilization of TPE infusion sets and further reduce carbon footprints.
- Digital green traceability: Use IoT technology to track the full-lifecycle carbon footprint of TPE infusion sets from raw materials to disposal, providing data support for corporate ESG reporting and green procurement by medical institutions.
Conclusion
The value of TPE infusion sets has long transcended the single dimension of “replacing PVC”. As an ideal intersection of safety and environmental protection in medical consumables, they are a common choice for enterprise compliance upgrading, medical institution cost reduction and efficiency improvement, and industry green transformation. When the industry shifts from a single perspective of “clinical safety” to a global perspective of “full-lifecycle green value”, TPE infusion sets will no longer be an “optional upgrade” but a standard future for the medical consumables industry